Bachem is a leading CDMO specialising in peptides and oligonucleotides for pharmaceutical and biotech applications.

Founded over 50 years ago, Bachem has established itself as a global leader in peptide and oligonucleotide development and manufacturing. With a commitment to innovation, the company serves the pharmaceutical, biotechnology, and research sectors, offering a full spectrum of services from research-grade production to GMP-compliant manufacturing. Its integrated capabilities, advanced technologies, and focus on quality ensure efficient delivery of APIs and biologics.

Key Products & Services:

• Custom Peptides: Research, clinical, and commercial applications.
• Oligonucleotides: Synthesis and manufacturing.
• Commercial APIs: Generic and innovative peptide-based APIs.
• Analytical & CMC Development Services.
• Research Products: Catalogues of peptides and biochemicals.

Bachem’s strong focus on sustainability and innovation drives its mission to enhance patient health globally, making it a trusted partner in the life sciences industry.